Post Image

DuoNovo: How Long-Read Sequencing Can Improve Access to Genetic Testing

  • Leandros Boukas, MD, PhD
  • May 13, 2026

Introduction:   Many of us are familiar with the classic conceptualization of genetic disorders as disorders that run in families, often illustrated in large, multi-generation pedigrees. However, the widespread application of sequencing technologies as a diagnostic tool for rare disorders has now rewritten the textbook. One of the ways it has …

Read More
Post Image

The Power of Progress: Philip's NF1 Clinical Trial Experience

  • Meagan Farmer
  • May 22, 2024

We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …

Read More